{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:22:48Z","timestamp":1785698568914,"version":"3.56.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015794","name":"Foundation for Alcohol Research and Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jaip.2021.07.017","type":"journal-article","created":{"date-parts":[[2021,7,27]],"date-time":"2021-07-27T04:56:38Z","timestamp":1627361798000},"page":"3282-3287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Management of Eosinophilic Esophagitis During Oral Immunotherapy"],"prefix":"10.1016","volume":"9","author":[{"given":"Derek K.","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Vickery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2021.07.017_bib1","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2021.07.017_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2020.03.021","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the Joint Task Force on Allergy-Immunology Practice Parameters","volume":"124","author":"Rank","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib3","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.07.009","article-title":"Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: proceedings of the AGREE Conference","volume":"155","author":"Dellon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.07.017_bib4","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1007\/s10620-016-4204-4","article-title":"The 2010-2015 prevalence of eosinophilic esophagitis in the USA: a population-based study","volume":"61","author":"Mansoor","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jaip.2021.07.017_bib5","article-title":"Prevalence and geographic distribution of pediatric eosinophilic esophagitis in the 2012 US Medicaid population","volume":"8","author":"McGowan","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib6","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.1016\/j.jaip.2021.06.002","article-title":"Clinicopathologic correlations in eosinophilic gastrointestinal disorders","volume":"9","author":"Pesek","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib7","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 Oral immunotherapy for peanut allergy","volume":"379","author":"Vickery","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2021.07.017_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jaip.2016.11.010","article-title":"Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab","volume":"5","author":"Burk","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.anai.2017.11.016","article-title":"Eosinophilic esophagitis and symptoms possibly related to eosinophilic esophagitis in oral immunotherapy","volume":"120","author":"Petroni","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib10","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.anai.2014.08.004","article-title":"Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis","volume":"113","author":"Lucendo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jaip.2018.05.010","article-title":"Eosinophilic esophagitis is a late manifestation of the allergic march","volume":"6","author":"Hill","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib12","doi-asserted-by":"crossref","first-page":"AB134","DOI":"10.1016\/j.jaci.2016.12.441","article-title":"Eosinophilic esophagitis like oral immunotherapy related syndrome (ELORS)","volume":"139","author":"Silvers","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib13","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.3389\/fimmu.2018.02624","article-title":"Baseline gastrointestinal eosinophilia is common in oral immunotherapy subjects with IgE-mediated peanut allergy","volume":"9","author":"Wright","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.05.019","article-title":"Gastrointestinal eosinophil responses in a longitudinal, randomized trial of peanut oral immunotherapy","volume":"19","author":"Wright","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.07.017_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaip.2016.11.020","article-title":"The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy","volume":"5","author":"Hill","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.02.004","article-title":"Resolution of acute IgE-mediated allergy with development of eosinophilic esophagitis triggered by the same food","volume":"133","author":"Maggadottir","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.anai.2020.12.007","article-title":"Eosinophilic esophagitis may persist after discontinuation of oral immunotherapy","volume":"126","author":"Hamant","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib18","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ACI.0000000000000688","article-title":"Eosinophilic esophagitis as a complication of food oral immunotherapy","volume":"20","author":"Jin","year":"2020","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaip.2019.07.034","article-title":"Risk factors and treatment outcomes for oral immunotherapy-induced gastrointestinal symptoms and eosinophilic responses (OITIGER)","volume":"8","author":"Goldberg","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib20","article-title":"Long-term outcome of peanut oral immunotherapy facilitated initially by omalizumab","volume":"7","author":"Yee","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eclinm.2018.12.006","article-title":"A\u00a0phase 2 randomized controlled multisite study using omalizumab-facilitated rapid desensitization to test continued vs discontinued dosing in multifood allergic individuals","volume":"7","author":"Andorf","year":"2019","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jaip.2021.07.017_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2015.10.005","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow\u2019s milk allergy","volume":"137","author":"Wood","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib23","first-page":"1","article-title":"Efficacy and safety of oral immunotherapy along with omalizumab in children with severe cow\u2019s milk allergy","volume":"70","author":"Pajno","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.07.017_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.08.010","article-title":"Omalizumab facilitates rapid oral desensitization for peanut allergy","volume":"139","author":"MacGinnitie","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib25","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/nm.3281","article-title":"Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis","volume":"19","author":"Noti","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jaip.2021.07.017_bib26","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.019","article-title":"Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis","volume":"147","author":"Butz","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.07.017_bib27","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.07.039","article-title":"Budesonide orodispersible tablets maintain remission in a randomized, placebo-controlled trial of patients with eosinophilic esophagitis","volume":"159","author":"Straumann","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.07.017_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2021.07.017_bib29","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/PAS.0000000000001361","article-title":"Budesonide oral suspension significantly improves eosinophilic esophagitis histology scoring system results: analyses from a 12-week, phase 2, randomized, placebo-controlled trial","volume":"43","author":"Collins","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaip.2021.07.017_bib30","article-title":"Real-world experience with peanut oral immunotherapy: lessons learned from 270 patients","volume":"7","author":"Wasserman","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib31","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.14309\/ajg.0000000000000371","article-title":"One-hour esophageal string test: a nonendoscopic minimally invasive test that accurately detects disease activity in eosinophilic esophagitis","volume":"114","author":"Ackerman","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2021.07.017_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11938-019-00216-7","article-title":"New developments in the diagnosis and treatment of eosinophilic esophagitis","volume":"17","author":"Nhu","year":"2019","journal-title":"Curr Treat Options Gastroenterol"},{"key":"10.1016\/j.jaip.2021.07.017_bib34","author":"Dilollo"},{"key":"10.1016\/j.jaip.2021.07.017_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.anai.2018.05.005","article-title":"Minimally invasive biomarker studies in eosinophilic esophagitis: a systematic review","volume":"121","author":"Hines","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib36","article-title":"Joint Task Force for Allergy Practice Parameters, et\u00a0al. Making the GRADE in anaphylaxis management: toward recommendations integrating values, preferences, context, and shared decision making","volume":"124","author":"Shaker","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2021.07.017_bib37","author":"Sauer"},{"key":"10.1016\/j.jaip.2021.07.017_bib33","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/MPG.0000000000002583","article-title":"Monitoring eosinophilic esophagitis disease activity with blood eosinophil progenitor levels","volume":"70","author":"Henderson","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jaip.2021.07.017_bib38","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1016\/j.jaip.2021.07.031","article-title":"Emerging biologic therapies for eosinophilic gastrointestinal diseases","volume":"9","author":"Peterson","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib39","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1016\/j.jaip.2021.07.029","article-title":"Treatment of eosinophilic esophagitis: diet or medication?","volume":"9","author":"Chehade","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2021.07.017_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.05.014","article-title":"Efficacy of epicutaneous immunotherapy in children with milk-induced eosinophilic esophagitis","volume":"18","author":"Spergel","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2021.07.017_bib41","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/all.14659","article-title":"Sustained milk consumption after 2 years post-milk epicutaneous immunotherapy for eosinophilic esophagitis","volume":"76","author":"Spergel","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2021.07.017_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/ACI.0000000000000537","article-title":"Eosinophilic esophagitis during sublingual and oral allergen immunotherapy","volume":"19","author":"Cafone","year":"2019","journal-title":"Curr Opin Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821008187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219821008187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:20Z","timestamp":1761975020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219821008187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213219821008187"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2021.07.017","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Eosinophilic Esophagitis During Oral Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2021.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}